Advertisement
U.S. drug companies have started the new year by raising the prices of hundreds of medications.

Price Hikes for Hundreds of Medications

0
Prices of 411 drugs have increased an average of 5 percent
From 2014 to 2016

2014 to 2016 Saw Decline in U.S. Adults Prescribed Opioids

0
Decrease larger for U.S. adults reporting moderate or more severe pain versus less-than-moderate pain
In a new evidence-based clinical practice guideline

Guideline Issued for Testosterone Therapy in Adult Men

0
Testosterone recommended for men with sexual dysfunction who want to improve sexual function
Intermittently scanned continuous glucose monitoring results in higher treatment satisfaction among adults with type 1 diabetes

New Continuous Glucose Monitor May Cut Hypoglycemia in T1DM

0
Adults using intermittently scanned continuous glucose monitoring also report less work absenteeism
In a special communication article

Public Policy Recs Updated for Familial Hypercholesterolemia

0
Goals include enhancing awareness of familial hypercholesterolemia as a global public health issue
Modestly worse patient experiences are seen following hospital acquisition by another hospital

Patient Experiences Modestly Worse After Hospital Acquisition

0
No significant differential changes found in 30-day readmission rates or 30-day mortality

December 2019 Briefing – Pharmacy

0
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for December 2019. This roundup includes the latest...
For patients with elevated lipoprotein(a) levels and established cardiovascular disease

APO(a)-LRX Found to Reduce Lipoprotein(a) Levels

0
Dose-dependent reduction found in patients with elevated lipoprotein(a) levels, cardiovascular disease
In a report published in the Jan. 3 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report

Guidance Developed for Providing Quality STD Care

0
Eight sections of report include sexual history and physical exams, prevention, screening, treatment
A novel cathepsin K inhibitor

MIV-711 No Better Than Placebo for Pain Relief in Knee OA

0
But significant reductions seen in medial femoral bone area progression, medial femoral cartilage thinning